| 中文别名 |
2-[3-甲基-4-(2,2,2-村氟乙氧基)-2-吡啶基]亚磺酰]-1H-苯并咪唑;2-[[[3-甲基-4-(2,2,2-三氟乙氧基)-2-吡啶基]甲基]亚磺酰基]-1H-苯并咪唑;2-(((3-甲基-4-(2,2,2-三氟乙氧基)-2-吡啶基)甲基)亚磺酰基)-1H-苯并咪唑;2-[[[3-甲基-4-(2,2,2-三氟乙氧基)-2-吡啶基]甲基]亚磺酰]-1H-苯并咪唑;郎索那唑;兰索拉唑及中间体;1-(迭氮基甲基)-4-甲基-苯;Lansoprazole 兰索拉唑;Lansoprazole,certified 标准品;奥卡西平;维甲酸;盐酸氟桂利嗪;盐酸去甲万古霉素;兰索拉唑(标准品);兰索拉唑;达克普隆;兰索拉唑微丸8.5%;氘代兰索拉唑-D4 同位素标记物;兰索拉唑, 一种质子泵抑制剂(PPI);兰索拉唑(对照品) |
| 英文别名 |
1h-benzimidazole,2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)su;2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-1h-benz;PREVACID;OGAST;LANSAPRAZOLE;LANSOX;2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole;AG1749;AG-1749;Ketian;Lancid;Lanz;LANZOR;Promp;Ulpax;Zoton;PREVONCO LANSOPRAZOLE;2-[[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzoimidazole;Alter;Cinfa;Davur;Lanso;Lansoprazole impurities;Lansoprazole IMpurity;Bamalite;Monolitum;Lansoprazol;Ogastro;Limpidex;Agopton;Opiren;Prevacid SoluTab;Takepron;Lanzopral;Lansoprazolum;Lansopep;Lanproton;Mesactol;Lasoprol;Blason;Prezal;Lanston;Aprazol;Pro Ulco;Prosogan;Ilsatec;Compraz;Suprecid;Zoprol;Dakar;Prevacid Iv;AG 1749;Lansoprazol [INN-Spanish];Lansoprazolum [INN-Latin];Lanzo;Prevacid NapraPAC;Prevacid 24HR;Lansoprazole [USAN:BAN:INN];Lansoprazole;2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfinyl]-1H-benzimidazole;103577-45-3;LANSOPRAZOLE (EP MONOGRAPH);Ogastoro;ABT-006;cid_3883;HMS3269D15;Tox21_301023;PREVPAC COMPONENT LANSOPRAZOLE;LANSOPRAZOLE [USP MONOGRAPH];Lansoprazole, European Pharmacopoeia (EP) Reference Standard;2-[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl-methanesulfinyl]-1H-benzimidazole;2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]-methyl]sulfinyl]benzimidazole;Prestwick1_001072;Prestwick0_001072;DTXSID4023200;Tox21_110184;2-[[[3-METHYL-4-(2,2,2-TRIFLUORO-ETHOXY)-PYRIDIN-2-YL]METHYL]SULFINYL]-1H-BENZO[D]IMIDAZOLE;2-(((3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)PYRIDIN-2-YL)METHYL)SULFINYL)-1H-BENZIMIDAZOLE;SPBio_002992;NCGC00015615-07;HMS3264E12;HMS3371E21;Opera_ID_1676;CHEMBL480;Lansoprazole for peak identification;Sunmark Lansoprazole;EU-0100709;HMS2052F05;FT-0670721;SR-01000000169-9;Kirkland Signature Lansoprazole;2-[(R)-[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole;Lansoprazol (INN-Spanish);Spectrum2_000444;NSC-758638;NSC 758638;LANSOPRAZOLE [WHO-DD];KBio2_004628;2-[3-methyl-4-(2,2,2-trifluoro-ethoxy)pyridin-2-ylmethanesulfinyl]-benzimidazole;HMS1571G06;NCGC00015615-01;Spectrum_001580;Lansoprazole, British Pharmacopoeia (BP) Reference Standard;SPECTRUM1503926;A02BC03;SB19127;NCGC00015615-08;NS00000543;Lansoprazole impurity standard;SCHEMBL22365;NCGC00254925-01;CHEBI:6375;Z1501485356;Up and Up Lansoprazole;AC-1233;A800764;KS-1075;Lopac0_000709;L0233;2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyrid-2-yl]methylsulfinyl]benzimidazole;Lansoprazole DR;2-[[3-methyl-4-[2,2,2-tris(fluoranyl)ethoxy]pyridin-2-yl]methylsulfinyl]-1H-benzimidazole;2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]benzimidazole;HY-13662;D00355;Pharmakon1600-01504282;LANSOPRAZOLE [MI];Lansoprazole for peak identification, European Pharmacopoeia (EP) Reference Standard;Lanzol-30;2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-ben... |
微信公众号
客服
